Business
ABATTIS FILES FOR INJUNCTIVE RELIEF IN WASHINGTON STATE AND CLAIMS DAMAGES AGAINST FORMER EMPLOYEES, BUSINESS ASSOCIATES AND COMPETITOR, AFFINOR GROWERS, INC. AND CERTAIN OF ITS ASSOCIATES
ABATTIS FILES FOR INJUNCTIVE RELIEF IN WASHINGTON STATE AND CLAIMS DAMAGES AGAINST FORMER EMPLOYEES, BUSINESS ASSOCIATES AND COMPETITOR, AFFINOR GROWERS, INC. AND CERTAIN OF ITS ASSOCIATES.
About this update from Abattis Bioceuticals Corp
[{"type":"text","content":"\n\nv\\:* {behavior:url(#default#VML);}\no\\:* {behavior:url(#default#VML);}\nw\\:* {behavior:url(#default#VML);}\n.shape {behavior:url(#default#VML);}\n\n\n \n 0\n 0\n 1\n 1681\n 9587\n Abattis Bioceuticals Corp.\n 79\n 22\n 11246\n 14.0\n \n\n\n\n \n Normal\n 0\n false\n \n \n \n false\n false\n false\n \n EN-US\n JA\n X-NONE\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n \n\n\n\n\n /* Style Definitions */\ntable.MsoNormalTable\n\t{mso-style-name:\"Table Normal\";\n\tmso-tstyle-rowband-size:0;\n\tmso-tstyle-colband-size:0;\n\tmso-style-noshow:yes;\n\tmso-style-priority:99;\n\tmso-style-parent:\"\";\n\tmso-padding-alt:0cm 5.4pt 0cm 5.4pt;\n\tmso-para-margin:0cm;\n\tmso-para-margin-bottom:.0001pt;\n\tmso-pagination:widow-orphan;\n\tfont-size:12.0pt;\n\tfont-family:\"Futura Lt BT\",\"sans-serif\";\n\tmso-ansi-language:EN-US;}\n\n\n\n\n\n\n\n ABATTIS FILES FOR INJUNCTIVE RELIEF IN WASHINGTON STATE AND CLAIMS\nDAMAGES AGAINST FORMER EMPLOYEES, BUSINESS ASSOCIATES AND COMPETITOR, AFFINOR\nGROWERS, INC. AND CERTAIN OF ITS ASSOCIATES Vancouver, BC –\nOctober 24, 2014 - Abattis Bioceuticals Corp. (the “Company” or “Abattis”)\n(OTCQX: ATTBF) (CSE: ATT),\nwishes to advise its shareholders that it has today, in U.S. Federal court in\nWashington State, filed suit for damages and injunctive relief against prior\nemployees of PhytaLab (Dr. Kaleb Lund and Ms. Lauren Hilty), a former business\nassociate (James Baxter), a competitor (Affinor Growers, Inc.), its director\nand former Abattis director (Nick Brusatore) and an employee of Herbal\nAnalytics LLC (Erin Leary). PhytaLab is owned\n51% by Abattis through its subsidiary, Abattis Bioceuticals International\nInc. PhytaLab, originally founded as\nPhytalytics LLC, was the first laboratory to provide testing services in\nWashington State for medical Cannabis under State law. PhytaLab recently announced that it received provisional\nc...